Body Supplements – Nefiracetam Vega Caps 200mg (30 pcs)

Introduction

Nefiracetam Vega Caps 200mg contain N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide. It is a racetam with a 2-oxopyrrolidine ring coupled to a 2,6-dimethylaniline. The development code is DM-9384. It is not piracetam, which has no aryl ring, and it is not aniracetam, which is a 4-methoxybenzoyl compound.

It has been studied as an investigational cognition drug. It is not an FDA-approved medicine. Each capsule is labeled 200 mg. That number is the declared content of the unit. It is not a recommended amount for any use. Excipients must be listed, because the capsule mass is not the same as the nefiracetam content.

Key features and benefits – Buy Nefiracetam Vega Caps 200mg

• Defined racetam anilide. The 2,6-dimethylphenyl group is the structural difference from piracetam and aniracetam.
• Unit fill. A capsule declares 200 mg, which supports content checks without weighing bulk powder.
• Documented identity. CAS 77191-36-7, formula C14H18N2O2, molar mass 246.3 g·mol−1.
• Separable from excipients. HPLC assay can distinguish the active from capsule fillers.
• Laboratory-only handling. Intended for controlled chemical and in vitro work, not as a dietary supplement.

Specifications of Buy Nefiracetam Vega Caps 200mg

Applications in research

Appropriate uses are non-clinical and institutionally approved:

• Content-uniformity and assay checks on a labeled 200 mg capsule.
• HPLC, LC-MS, and NMR identification of nefiracetam after extraction.
• Forensic differentiation from piracetam, aniracetam, and phenylpiracetam.
• Impurity profiling of the dimethylanilide racetam.

Do not describe or imply oral use or any supplement protocol. Do not treat 200 mg as a dose.

Purity and testing

A defensible product claim rests on the batch certificate and an assay of the capsule.

• HPLC of the extracted fill for chromatographic purity and for assayed content against the 200 mg label.
• 1H NMR or LC-MS for the oxopyrrolidine and the 2,6-dimethylphenyl ring.
• Mass spectrometry for the molecular ion consistent with C14H18N2O2.
• A check that the sample is not aniracetam or piracetam.
• Excipient list, and a check that fillers do not co-elute with the active.
• Content uniformity across units if the supplier states it.

Store the COA with the lot number. Do not use a piracetam CAS number for this capsule.

Disclaimer

For laboratory research use only. Not for human or veterinary consumption, not for diagnostic or therapeutic use, and not a food, drug, or dietary supplement. The 200 mg marking is fill weight, not a dosing instruction. Nefiracetam is not an FDA-approved medicine. Legal status varies. Buyers are responsible for confirming legality, import rules, and institutional approval before ordering or handling. Handle with standard laboratory PPE and dispose of waste under local chemical rules. No statement on this page is a claim of safety, efficacy, or fitness for any human application.

Frequently asked questions

What is in the Vega Cap?
The active is nefiracetam, N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide, formula C14H18N2O2. Body Supplements and Vega Caps are product names. Fillers must be listed separately.

What does 200 mg mean?
It is the declared amount of nefiracetam per capsule. It is not a recommended dose. Confirm that the figure is active content, not total capsule weight.

Is this the same as piracetam or aniracetam?
No. Piracetam has no aryl ring. Aniracetam is the 4-methoxybenzoyl racetam. Nefiracetam is the 2,6-dimethylanilide, CAS 77191-36-7, 246.3 g·mol−1.

Which CAS number applies?
CAS 77191-36-7.

How should capsules be stored?
Sealed, cool, dry, and protected from light. Keep the lot number with the COA.

Can they be used in humans?
No. They are not sold here as a medicine or supplement. Check local law before purchase.

What analytical methods confirm identity?
HPLC assay against the 200 mg label, NMR or LC-MS for the dimethylphenyl and oxopyrrolidine signals, and mass spectrometry consistent with C14H18N2O2. An aniracetam peak does not confirm nefiracetam.